Tracy Zimmermann
Förmögenhet: - $ per 2026-10-31
Förmögenhet: - $ per 2026-10-31
Tracy Zimmermann is Chief Scientific Officer at City Therapeutics, Inc. since 2024.
Formerly, Dr. Zimmermann was Chief Development Officer at Generation Bio Co. from 2020 to 2024 and Senior Director-Research at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Education includes undergraduate studies at Lehigh University and a doctorate from the University of Colorado Boulder.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
-.--% | 2026-10-16 | 0 ( -.--% ) | - $ | 2026-10-31 |
| Företag | Position | Start |
|---|
| Företag | Position | Slut |
|---|---|---|
| GENERATION BIO CO. | Företagsledare/Principal | 2024-01-28 |
| ALNYLAM PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-09-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Boulder
University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generation Bio Co.
Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån